CogMe for the Prevention and Early Detection of Delirium
CogMe
Evaluation of the CogMe Technology Platform for the Prevention and Early Detection of Delirium Among Older Patients in an Acute Hospital Setting: A Proof of Concept Study
1 other identifier
interventional
100
1 country
1
Brief Summary
This study is designed as a prospective interventional study to evaluate the CogMe system for early detection and prevention of delirium. The study will collect physiological and cognitive measurements to evaluate the ability of the CogMe system to predict and detect delirium and to aid the development of future delirium prevention methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 7, 2022
CompletedFirst Posted
Study publicly available on registry
April 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 5, 2023
September 1, 2023
2.3 years
March 7, 2022
September 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The detection of delirium by the CogMe system
Time between the detection of delirium by the CogMe Data Analytics model and the first diagnosis of delirium based on the Confusion Assessment Method (CAM) instrument.
24 hours
Study Arms (1)
CogMe Personal Assistant (PA)
EXPERIMENTALThe CogMe PA is a dedicated application built by CogMe with the purpose of assessing the cognitive functions of patients and providing them with a short and stimulating interaction. The application runs on a standard tablet. The CogMe PA is designed to be easily understandable and usable also for older adults with little or no experience in mobile applications. The questions in the Q\&A session are based on validated cognitive tests shown to be associated with delirium and are built to assess the subjective wellbeing and cognitive function of the patients. The repeated use of the application will allow to detect any changes or anomalies during the hospitalization period.
Interventions
Twice a day, in the morning and evening, the electronic tablet with the CogMe PA will be given to the patient by the research assistant. Patients will be asked to respond to a short question and answer (Q\&A) session of approximately 5-10 minutes duration. This intervention will continue throughout the hospitalization period, estimated at approximately 5 days.
Eligibility Criteria
You may qualify if:
- Male and female patients aged 65 years of age and older.
- Patients with an expected length of hospitalization of 4 days or longer.
- Patients who are conscious and cognitively able to provide written informed consent as suggested by a score of 0 on 4AT screening.
- Patients who have no diagnosis of delirium prior to enrollment.
You may not qualify if:
- Male and female patients younger than 65 years of age.
- Patients with an expected length of hospitalization of less than 4 days.
- Patients with uncorrected visual or hearing impairment.
- Patients with impaired consciousness or cognitive impairment as determined by a score of 1 or more on 4AT screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rambam Health Care Campuslead
- CogMe Ltdcollaborator
Study Sites (1)
Rambam Health Care Campus
Haifa, North, 3109601, Israel
Related Publications (6)
Inouye SK. Delirium in older persons. N Engl J Med. 2006 Mar 16;354(11):1157-65. doi: 10.1056/NEJMra052321. No abstract available.
PMID: 16540616RESULTHshieh TT, Yang T, Gartaganis SL, Yue J, Inouye SK. Hospital Elder Life Program: Systematic Review and Meta-analysis of Effectiveness. Am J Geriatr Psychiatry. 2018 Oct;26(10):1015-1033. doi: 10.1016/j.jagp.2018.06.007. Epub 2018 Jun 26.
PMID: 30076080RESULTYu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018 Oct;2(10):719-731. doi: 10.1038/s41551-018-0305-z. Epub 2018 Oct 10.
PMID: 31015651RESULTO'Keeffe ST, Lavan JN. Predicting delirium in elderly patients: development and validation of a risk-stratification model. Age Ageing. 1996 Jul;25(4):317-21. doi: 10.1093/ageing/25.4.317.
PMID: 8831879RESULTInouye SK, Bogardus ST Jr, Baker DI, Leo-Summers L, Cooney LM Jr. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life Program. J Am Geriatr Soc. 2000 Dec;48(12):1697-706. doi: 10.1111/j.1532-5415.2000.tb03885.x.
PMID: 11129764RESULTInouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941.
PMID: 2240918RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tzvi Dwolatzky, MD MBBCh
Rambam Health Care Campus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Geriatrics
Study Record Dates
First Submitted
March 7, 2022
First Posted
April 5, 2022
Study Start
March 1, 2022
Primary Completion
June 30, 2024
Study Completion
December 31, 2024
Last Updated
September 5, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
Data will be available to other researchers on request .